Jump to main content
Jump to site search


Selective Recognition of DNA Defects By Cyclometalated Ir(III) complexes

Abstract

Selective detection of DNA defects is an attractive approach for early detection of various tumors and diseases. Ru(II), Rh(III) and hybrid complexes have been reported in this regard. Here, we presented three heteroleptic cyclometalated Ir(III) complexes [Ir(phpy)2(imiphen)]+(Ir-1), [Ir(phpy)2(furphen)]+(Ir-2) and [Ir(phpy)2(faqphen)]+(Ir-3) where imiphen: 2-(1H-imidazol-2-yl)-1Himidazo[ 4,5-f][1,10]phenanthroline; furphen: 2-(furan-2-yl)-1H-imidazo[4,5-f][1,10]phenanthroline and faqphen: 6-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)-4a,9a-dihydroanthracene-9,10-dione) that have been synthesized and characterized by analytical techniques. All the three complexes recognize the DNA defects with high selectivity as Ir-1 recognizes the abasic site opposite T and CA mismatch, Ir-2 recognizes Ab:G and Ir-3 recognizes the TT mismatch preferably. The results from this study further emphasize that the development of new luminescence probes require fine-tuning of the ligand structure and the choice of metal center to improve the selectivity in recognition of DNA defects.

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 Mar 2019, accepted on 02 Aug 2019 and first published on 05 Aug 2019


Article type: Communication
DOI: 10.1039/C9DT01225G
Dalton Trans., 2019, Accepted Manuscript

  •   Request permissions

    Selective Recognition of DNA Defects By Cyclometalated Ir(III) complexes

    D. D. Paul Elisa Sundar, R. P. Malapati and V. Ganesan, Dalton Trans., 2019, Accepted Manuscript , DOI: 10.1039/C9DT01225G

Search articles by author

Spotlight

Advertisements